|

Copper Cu 64 Dotatate Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 4: 1

Top Sponsors

  • Vanderbilt-Ingram Cancer Center1

Indications

  • Pancreatic Neuroendocrine Tumor G21
  • Pancreatic Neuroendocrine Tumor G11
  • Metastatic Digestive System Neuroendocrine Neoplasm1
  • Digestive System Neuroendocrine Tumor G21
  • Digestive System Neuroendocrine Tumor G11

Nashville, Tennessee1 trial

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Vanderbilt University/Ingram Cancer Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.